Key points are not available for this paper at this time.
spp. heterologous hosts up until 2024. We then compare the hosts that have been tested and discuss ongoing development efforts to improve access to new natural products in titers sufficient for drug development and industrial applications.
Heard et al. (Mon,) studied this question.